Is Nu Skin Enterprises profitable in 2025?

Yes on a GAAP basis: FY2025 EPS was $3.18 versus a loss of $2.95 in FY2024, though excluding the Mavely sale gain EPS was $1.27. Revenue still fell 14.3% to $1.485 billion from $1.732 billion in 2024, so profit came mainly from a one time asset sale, not operating strength, as of Feb 12, 2026.

Is Nu Skin's revenue shrinking?

Yes, sharply. Revenue peaked at $2.25 billion in 2015 and fell to $1.485 billion in 2025, with Q1 2026 revenue down another 12% year over year to $320.6 million, reported Feb 12, 2026. Customer and affiliate counts also fell double digits in the same period.

Could AI replace Nu Skin's distributor network?

Partly already underway. Nu Skin's Paid Affiliates fell 8% and Sales Leaders fell 13% year over year in Q1 2026 as AI powered DTC personalization apps and telehealth substitutes erode the recruitment funnel the MLM model depends on. Nu Skin's own response is the AI powered Prysm iO device, launched to consumers April 2, 2026.

Who is Nu Skin's biggest competitor?

Amway and Herbalife dominate the direct selling category Nu Skin competes in. Amway generates roughly $7.4 to $8.9 billion and Herbalife roughly $5.0 to $5.8 billion in revenue, versus Nu Skin's $1.485 billion in 2025, per data cited July 7, 2026, positioning Nu Skin as a mid tier, declining player.

Is Nu Skin facing lawsuits over its business model?

Yes. Nu Skin Enterprises v. Raab is an unresolved class action alleging violations of Washington's Antipyramid Promotional Scheme Act and RICO. The 10th Circuit affirmed a stay of Nu Skin's arbitration petition on Nov 14, 2025, and the case remains active as of that date.

What is Nu Skin's Prysm iO and does it matter financially?

Prysm iO is an AI powered hyperspectral skin scanning device that generates a Nutrition Health Score, launched to US consumers April 2, 2026 at $375. Management guides it to add only about $30 million in 2026 revenue, roughly 2% of Nu Skin's $1.49 billion base, per the Feb 13, 2026 10-K.

Consumer brands · United States

Nu Skin Enterprises, Inc.

nuskin.com ↗

Nu Skin sells anti-aging skincare and supplements through a shrinking network of independent distributors.

Little protection left

Assessed 23 July 2026 · Evidence as of 23 July 2026

Not much stands between this business and its pressures.

On the recordSince 23 July 2026 · Checkable from August 10, 2026 · Every call on the record Checkpoint: Q2 2026 earnings release, watch for Paid Affiliate and Sales Leader counts

The call

Nu Skin's distributor base is shrinking every quarter while its Prysm iO device remains a small fraction of total revenue.

Nu Skin Enterprises sells skincare and wellness products mainly through independent distributors who recruit other sellers, rather than stores or websites. The distributor system is breaking down fast (distributors down 8% to 14% depending on tier in early 2026), making it hard for the company to replace lost sales. Rivals like Amway and Herbalife use the same playbook but are bigger, while direct-to-consumer beauty brands on Instagram and GLP-1 drugs for weight loss are pulling customers away from the core product, and new AI-powered skincare apps let people skip the distributor middleman entirely. The one thing that could reset the picture is if the new Prysm iO skincare device takes off and becomes a genuine bestseller, but it is currently only a tiny part of company revenue.

Why

AI pressure: AI-powered DTC personalization apps and subscription skincare tools. Apps can now recommend skincare and supplement routines directly to consumers, cutting out the need for a paid distributor entirely. Could AI do the core job? Yes, likely.

Bigger players: Amway, Herbalife, and GLP-1 weight loss drugs from Novo Nordisk and Eli Lilly. Bigger direct sellers keep more distributors, while GLP-1 drugs pull customers away from weight management supplements entirely. Could a giant copy it? Yes, easily.

What protects it. A recurring base of loyal long-term customers and Sales Leaders still generates cash even as the network shrinks.

What would change this call

Q2 2026 earnings (Aug 10, 2026) paid affiliate and sales leader counts vs prior quarter. Shows whether distributor base decline is stabilizing or still accelerating.
Prysm iO device and subscription revenue reported for FY2026 vs $30M guidance. Shows whether the turnaround product is scaling beyond a token contribution.
Outcome of Raab pyramid-scheme litigation (10th Circuit stay, venue decision). Shows whether legal exposure removes or worsens a key overhang on the business model.

Key numbers

Revenue fell to $1.49B in 2025 from $1.73B in 2024 (2026-02-12)
Sales Leaders down 13% year over year in Q1 2026 (2026-02-12)
Stock at $5.04, down from all-time high of $140.50 (2026-07-23)

Named risks

Double digit YoY declines in customers, Paid Affiliates and Sales Leaders through Q1 2026. Severity: high
Unresolved Raab pyramid scheme class action alleging RICO and antipyramid statute violations. Severity: high
Prysm iO turnaround thesis is only about 2% of revenue guided for 2026 against a shrinking base. Severity: high
Planned Credit Agreement refinancing in H1 2026 amid declining revenue and microcap status. Severity: medium
Executive turnover, including Chief Product Officer resignation in May 2026. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Amway	losing to	Amway revenue $7.4 to $8.9B vs Nu Skin $1.485B in 2025, per data cited Jul 7, 2026
Herbalife	losing to	Herbalife revenue $5.0 to $5.8B vs Nu Skin $1.485B in 2025, per data cited Jul 7, 2026
DTC skincare and telehealth GLP-1 substitutes	losing to	Nu Skin Paid Affiliates down 8%, Sales Leaders down 13%, customers down 14% YoY in Q1 2026
AI powered DTC personalization apps	contesting	Nu Skin launched AI powered Prysm iO device to consumers Apr 2, 2026 to counter substitution

Questions people ask

Is Nu Skin Enterprises profitable in 2025?: Yes on a GAAP basis: FY2025 EPS was $3.18 versus a loss of $2.95 in FY2024, though excluding the Mavely sale gain EPS was $1.27. Revenue still fell 14.3% to $1.485 billion from $1.732 billion in 2024, so profit came mainly from a one time asset sale, not operating strength, as of Feb 12, 2026.
Is Nu Skin's revenue shrinking?: Yes, sharply. Revenue peaked at $2.25 billion in 2015 and fell to $1.485 billion in 2025, with Q1 2026 revenue down another 12% year over year to $320.6 million, reported Feb 12, 2026. Customer and affiliate counts also fell double digits in the same period.
Could AI replace Nu Skin's distributor network?: Partly already underway. Nu Skin's Paid Affiliates fell 8% and Sales Leaders fell 13% year over year in Q1 2026 as AI powered DTC personalization apps and telehealth substitutes erode the recruitment funnel the MLM model depends on. Nu Skin's own response is the AI powered Prysm iO device, launched to consumers April 2, 2026.
Who is Nu Skin's biggest competitor?: Amway and Herbalife dominate the direct selling category Nu Skin competes in. Amway generates roughly $7.4 to $8.9 billion and Herbalife roughly $5.0 to $5.8 billion in revenue, versus Nu Skin's $1.485 billion in 2025, per data cited July 7, 2026, positioning Nu Skin as a mid tier, declining player.
Is Nu Skin facing lawsuits over its business model?: Yes. Nu Skin Enterprises v. Raab is an unresolved class action alleging violations of Washington's Antipyramid Promotional Scheme Act and RICO. The 10th Circuit affirmed a stay of Nu Skin's arbitration petition on Nov 14, 2025, and the case remains active as of that date.
What is Nu Skin's Prysm iO and does it matter financially?: Prysm iO is an AI powered hyperspectral skin scanning device that generates a Nutrition Health Score, launched to US consumers April 2, 2026 at $375. Management guides it to add only about $30 million in 2026 revenue, roughly 2% of Nu Skin's $1.49 billion base, per the Feb 13, 2026 10-K.

Timeline

2026-07-21Added to Russell Microcap Index; Q2 2026 earnings set for Aug 10, 2026; CPO resignation disclosed
2026-04-02Prysm iO AI device launched to US consumers at $375
2026-02-1310-K discloses affiliate declines, $30M Prysm iO revenue guidance, H1 2026 refinancing plan
2026-02-12FY2025 revenue reported at $1.485B, down 14.3%; Q1 2026 revenue $320.6M, down 12%
2025-11-1410th Circuit affirmed stay of arbitration petition in Raab pyramid scheme case
2025-03-27Washington Supreme Court issued venue decision in Raab v. Nu Skin Enterprises
2025-01-03Rhyz sold Mavely for about $250 million cash plus equity stake

Revision history

23 July 2026

First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.

In the same band

Lulus Fashion Lounge Holdings, Inc.Allbirds Esprit Holdings Limited